Lusvertikimab (OSE-127) is a humanized anti-IL7R antibody with anti-leukemic efficacy that reduces leukemic load in xenograft ALL through antibody-dependent phagocytosis and may be used to study leukemia.
Purity:
95.00%
CAS Number:
[2375835-91-7]
Target:
IL Receptor|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted